Stay updated on Study CB-839 + Paclitaxel in TNBC: Clinical Trial
Sign up to get notified when there's something new on the Study CB-839 + Paclitaxel in TNBC: Clinical Trial page.

Latest updates to the Study CB-839 + Paclitaxel in TNBC: Clinical Trial page
- Check3 days agoChange DetectedThe page's revision label was updated from v3.6.5 to v3.6.6. This indicates a minor update to the page framework or content version rather than changes to study details or eligibility information.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page revision label was updated from v3.6.4 to v3.6.5, indicating a small maintenance update to the page. This change does not modify the study details, eligibility criteria, or listed locations.SummaryDifference0.0%

- Check38 days agoChange DetectedThe page's revision label was updated from v3.6.3 to v3.6.4, indicating a new build of the site. This appears to be a platform-level update rather than a change to the study data.SummaryDifference0.0%

- Check60 days agoChange DetectedThe page shows a newer revision version (v3.6.3) for the study page, indicating a minor update or patch to the page layout or metadata without changing the study information.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page’s revision tag was updated to v3.6.2, replacing the previous v3.6.0. This indicates a routine update to the page rather than a change to substantive study information.SummaryDifference0.0%

- Check81 days agoChange DetectedThe page now indicates that recruitment has ended, introduces new guidance sections, and reworks the Interventional/Treatment presentation to reflect a content organization update.SummaryDifference0.3%

Stay in the know with updates to Study CB-839 + Paclitaxel in TNBC: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Study CB-839 + Paclitaxel in TNBC: Clinical Trial page.